Maria Palasis

Board Member

Maria Palasis has been serving as a member of our board of directors since 2022. Maria is currently President, Chief Executive Officer, and Board Director of Lyra Therapeutics, a combination product Biotechnology company she took public in 2020. Prior to Lyra Therapeutics, Maria was President, CEO, and Board Director of both Arsenal Medical and its spin-out, 480 Biomedical. Maria also served in senior leadership roles at Boston Scientific Corporation, Inc. focused on the development of drug-device combination products. She was elected into the National Academy of Engineering in 2021 for outstanding contributions to the design of medical devices and drug delivery systems. Maria serves on the Board of Directors of PanTher Therapeutics and is on the Advisory Board of MedExecWomen. She holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati and completed her postdoctoral fellowship in Molecular Biology at the University of Cincinnati School of Medicine.

Beta Bionics is a public benefit corporation.

We are committed to balancing purpose with profit and giving back to society as we fulfill our public benefit mission.

Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/resouces/user-guides, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/resources/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.